Álvaro Díaz‐González

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Mar Riveiro-Barciela

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Alejandro Forner

SPAIN

View details

Manuel Hernandez-Guerra

Gastroenterologist/Hepatologist/Professor

Hospital Universitario de Canarias

SPAIN

View details

Nely Díaz Mejía

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

Maria J. Monte

Universidad de Salamanca

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Álvaro Díaz‐González

Research Interests

Explore related searches

Contact this professor

Articles (10)

Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

Predicting liver‐related serious adverse events in patients with primary biliary cholangitis‐related cirrhosis treated with obeticholic acid

Low Baseline Plasma L-Glutamine Concentration Identifies Hepatocellular Carcinoma Patients at High Risk of Developing Early Gastrointestinal Adverse Events during Sorafenib Treatment

Beneficial Effect of Ursodeoxycholic Acid in Patients with ACOX2 Deficiency-Associated Hypertransaminasemia.

Budesonide in the first line treatment of patients with autoimmune hepatitis.

Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study.

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.

HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?

Collaborators (5)

Mar Riveiro-Barciela

Alejandro Forner

Manuel Hernandez-Guerra

Nely Díaz Mejía

Maria J. Monte

Make your next move.